NDC 0682-3001

BACMIN

Vitamin A Acetate, .alpha.-tocopherol Acetate, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Biotin, Calcium Pantothenate, Folic Acid, Cyanocobalamin, Flavone, Ferrous Fumarate, Chromic Chloride Cr-51, Magnesium Oxide, Manganese Gluconate, Cupric Oxide, Selenomethionine, And Zinc Oxide

BACMIN is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Marnel Pharmaceuticals, Inc.. The primary component is Vitamin A Acetate; .alpha.-tocopherol Acetate; Ascorbic Acid; Thiamine Mononitrate; Riboflavin; Niacinamide; Pyridoxine Hydrochloride; Biotin; Calcium Pantothenate; Folic Acid; Cyanocobalamin; Flavone; Ferrous Fumarate; Chromic Chloride Cr-51; Magnesium Oxide; Manganese Gluconate; Cupric Oxide; Selenomethionine; Zinc Oxide.

• Product ID: 0682-3001_ed775d39-46ec-4014-a727-232ab02b6f10
• NDC: 0682-3001
• Product Type: Human Prescription Drug
• Proprietary Name: BACMIN
• Generic Name: Vitamin A Acetate, .alpha.-tocopherol Acetate, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Biotin, Calcium Pantothenate, Folic Acid, Cyanocobalamin, Flavone, Ferrous Fumarate, Chromic Chloride Cr-51, Magnesium Oxide, Manganese Gluconate, Cupric Oxide, Selenomethionine, And Zinc Oxide
• Dosage Form: Tablet, Coated
• Route of Administration: ORAL
• Marketing Start Date: 2000-04-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Marnel Pharmaceuticals, Inc.
• Substance Name: VITAMIN A ACETATE; .ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CALCIUM PANTOTHENATE; FOLIC ACID; CYANOCOBALAMIN; FLAVONE; FERROUS FUMARATE; CHROMIC CHLORIDE CR-51; MAGNESIUM OXIDE; MANGANESE GLUCONATE; CUPRIC OXIDE; SELENOMETHIONINE; ZINC OXIDE
• Active Ingredient Strength: 2000 [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1
• Pharm Classes: Vitamin A [CS],Vitamin A [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0682-3001-01

100 TABLET, COATED in 1 BOTTLE (0682-3001-01)

• Marketing Start Date: 2000-04-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0682-3001-01 [00682300101]

BACMIN TABLET, COATED

• Marketing Category: UNAPPROVED DRUG OTHER
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2000-04-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
VITAMIN A ACETATE	2000 [iU]/1

OpenFDA Data

• SPL SET ID: 34beae32-51e4-4bdc-8ca5-1d8d79f193b2
• Manufacturer:
  • Marnel Pharmaceuticals, Inc.
• UNII:
  • 25X51I8RD4
  • 3A3U0GI71G
  • 68Y4CF58BV
  • 568ET80C3D
  • PQ6CK8PD0R
  • 9YY2F980SV
  • 964MRK2PEL
  • 9E8X80D2L0
  • 3LE3D9D6OY
  • R5L488RY0Q
  • S2V45N7G3B
  • U4M5Y13FGM
  • TLM2976OFR
  • V1XJQ704R4
  • SOI2LOH54Z
  • 8K0I04919X
  • 935E97BOY8
  • 6SO6U10H04
  • P6YC3EG204
• UPC Code:
  • 0306823001010

Pharmacological Class

• Vitamin A [CS]
• Vitamin A [EPC]
• Vitamin C [EPC]
• Ascorbic Acid [CS]
• Vitamin B6 Analog [EPC]
• Vitamin B 6 [Chemical/Ingredient]
• Analogs/Derivatives [Chemical/Ingredient]
• Vitamin B 12 [CS]
• Vitamin B12 [EPC]
• Calculi Dissolution Agent [EPC]
• Magnesium Ion Exchange Activity [MoA]
• Osmotic Laxative [EPC]
• Osmotic Activity [MoA]
• Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
• Increased Large Intestinal Motility [PE]
• Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Magnetic Resonance Contrast Activity [MoA]
• Paramagnetic Contrast Agent [EPC]